Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-337049
Filing Date
2025-12-30
Accepted
2025-12-30 16:01:03
Documents
1
Period of Report
2025-12-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3729
  Complete submission text file 0001193125-25-337049.txt   5397
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O COGENT BIOSCIENCES, INC. 200 CAMBRIDGE PARK DRIVE, SUITE 2500 CAMBRIDGE MA 02140
Business Address
Robinson John Edward (Reporting) CIK: 0001856514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 251614172